M
Michael Harvie
Researcher at University of Sri Jayewardenepura
Publications - 8
Citations - 73
Michael Harvie is an academic researcher from University of Sri Jayewardenepura. The author has contributed to research in topics: ELISPOT & Antibody. The author has an hindex of 1, co-authored 8 publications receiving 12 citations.
Papers
More filters
Posted ContentDOI
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals in Sri Lanka
Chandima Jeewandara,Inoka Sepali Aberathna,Pradeep Pushpakumara,Achala Kamaladasa,Dinuka Guruge,Deshni Jayathilaka,Banuri Gunesekara,Shyrar Tanussiya,Heshan Kuruppu,Thushali Ranasinghe,Shashika Dayarathne,Osanda Dissanayaka,Nayanathara Gamalath,Dinithi Ekanayaka,Mpdj Jayamali,Ayesha Wijesinghe,Madushika Dissanayaka,Deshan Madushanka,Tibutius T. P. Jayadas,Anushika Mudunkotuwa,Gayasha Somathilaka,Michael Harvie,Thashmi Nimasha,Saubhagya Danasekara,Ruwan Wijayamuni,Lisa Schimanski,Tiong Kit Tan,Tao Dong,Alain Townsend,Graham S. Ogg,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +31 more
TL;DR: In this article, the authors investigated the immunogenicity of the vaccine, in individuals in Sri Lanka, and measured SARS-CoV-2-specific antibodies were measured in 282 individuals who were seronegative at baseline, and ACE2 receptor blocking antibodies, antibodies to the receptor binding domain (RBD) of the wild type (WT), B.1.7, B.351 and B.617.
Posted ContentDOI
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals.
Chandima Jeewandara,Inoka Sepali Aberathna,Pradeep Darshana Pushpakumara,Achala Kamaladasa,Dinuka Guruge,Ayesha Wijesinghe,Banuri Gunasekera,Shyrar Tanussiya,Heshan Kuruppu,Thushali Ranasinghe,Shashika Dayarathne,Osanda Dissanayake,Nayanathara Gamalath,Dinithi Ekanayake,Jeewantha Jayamali,Deshni Jayathilaka,Madushika Dissanayake,Tibutius T. P. Jayadas,Anushika Mudunkotuwa,Gayasha Somathilake,Michael Harvie,Thashmi Nimasha,Saubhagya Danasekara,Ruwan Wijayamuni,Lisa Schimanski,Pramila Rijal,Tiong Kit Tan,Tao Dong,Alain Townsend,Graham S. Ogg,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +31 more
TL;DR: In this article, the authors investigated immune responses in a cohort of Sri Lankan individuals after the second dose of the Sinopharm/BBIBP-CorV vaccine, 12 weeks after ELISA, by measuring SARS-CoV-2 specific total antibodies.
Journal ArticleDOI
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka
Chandima Jeewandara,Dinuka Guruge,Inoka Sepali Abyrathna,Saubhagya Danasekara,Banuri Gunasekera,Pradeep Darshana Pushpakumara,Deshan Madhusanka,Deshni Jayathilaka,Thushali Ranasinghe,Gayasha Somathilake,Shyrar Tanussiya,Tibutius Tanesh Jayadas,Heshan Kuruppu,Nimasha Thashmi,Michael Harvie,Ruwan Wijayamuni,Lisa Schimanski,Tiong Kit Tan,Pramila Rijal,Julie Xiao,Graham S. Ogg,Alain Townsend,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +23 more
TL;DR: A serosurvey prior to initiation of the vaccination program to understand the extent of the SARS-CoV-2 outbreak was carried out in Sri Lanka as mentioned in this paper, where the overall seropositivity rate was 24.46%.
Posted ContentDOI
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
Chandima Jeewandara,Inoka Sepali Aberathna,Laksiri Gomes,Pradeep Darshana Pushpakumara,Saubhagya Danasekara,Dinuka Guruge,Thushali Ranasinghe,Banuri Gunasekera,Achala Kamaladasa,Heshan Kuruppu,Gayasha Somathilake,Osanda Dissanayake,Nayanathara Gamalath,Dinithi Ekanayake,Jeewantha Jayamali,Deshni Jayathilaka,Anushika Mudunkotuwa,Michael Harvie,Thashmi Nimasha,Ruwan Wijayamuni,Lisa Schimanski,Pramila Rijal,Tiong Kit Tan,Tao Dong,Alain Townsend,Graham S. Ogg,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +27 more
TL;DR: In this article, the authors compared antibody and T cell responses in two cohorts with two different dosing gaps, and found that both dosing schedules resulted in high levels of antibody and t cell responses post vaccination, although those with a longer dosing gap had a higher magnitude of responses.
Journal ArticleDOI
Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR
Laksiri Gomes,Chandima Jeewandara,Tibutius Pramanayagam Jayadas,Osanda Dissanayake,Michael Harvie,Dinuka Guruge,Vigeetha Withanage,Pasyodun Koralage Buddhika Mahesh,Wajira Rajapakse,Rajanthi Ramachandran,Venoden Dharmarajan,Indika Pathiraja,Anusha Sanjeewani,Priyantha Bandara,Geetha Nanayakkara,Vaithehi Francis,Ananda Kithsiri,Dilini Anushika Edirisinghe,Kaushalya De Silva,Ruwan Wijayamuni,Graham S. Ogg,Jesse J. Waggoner,Gathsaurie Neelika Malavige +22 more
TL;DR: In this article, a multiplex real-time qRT-PCR was used to identify SARS-CoV-2 variants of concern (VOCs) in 16/26 districts in Sri Lanka.